Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download ...

Fintel reports that on November 3, 2025, Barclays maintained coverage of DexCom (NasdaqGS:DXCM) with a Equal-Weight ...

Truist lowered the firm’s price target on DexCom (DXCM) to $82 from $94 and keeps a Buy rating on the shares. The company’s Q3 earnings and ...

DexCom (DXCM) stock ought to be included on your watchlist. Here is why – it is presently trading within the support range ($55.31 – $61.13), levels from ...

DexCom was hit with a consumer class action on Oct. 22 in California Southern District Court over allegations it made unauthorized design changes to its G6 and G7 continuous glucose monitors without ...

Jefferies Financial Group Inc. moved to soothe a growing fear among investors over the fallout from the bankruptcy of its client, auto-parts seller First Brands, by saying any impact to its finances ...

A view shows the Kremlin's towers, the Grand Kremlin Palace and cathedrals behind the wall in central Moscow, Russia, August 7, 2025. REUTERS/Evgenia Novozhenina MOSCOW (Reuters) -Russia said on ...

DexCom receives a BUY rating due to strong growth, expanding margins, and the launch of Stelo, the first OTC CGM for non-insulin users. DXCM raised its 2025 outlook, targeting $4.6B+ in revenue, 62% ...

Last week, the Committee on Revision of the Penal Code and California Policy Lab published a report looking at the recidivism rates of people resentenced under some of the state’s major criminal ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them. DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) ...

DexCom's devices are important to its customers' health. The company still has significant whitespace in its market. Despite potential obstacles, the stock is still attractive. Even so, the ...